237 related articles for article (PubMed ID: 7031015)
1. Molecular basis of steroid hormone action in breast cancer and its clinical implications.
Lunenfeld B; Geier A
Isr J Med Sci; 1981; 17(9-10):954-9. PubMed ID: 7031015
[TBL] [Abstract][Full Text] [Related]
2. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
Eckert RL; Katzenellenbogen BS
Cancer Res; 1982 Jan; 42(1):139-44. PubMed ID: 7053842
[No Abstract] [Full Text] [Related]
3. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.
Bagatell R; Khan O; Paine-Murrieta G; Taylor CW; Akinaga S; Whitesell L
Clin Cancer Res; 2001 Jul; 7(7):2076-84. PubMed ID: 11448926
[TBL] [Abstract][Full Text] [Related]
4. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
5. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
6. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
7. Steroid receptors in human breast cancer.
McGuire WL
Cancer Res; 1978 Nov; 38(11 Pt 2):4289-91. PubMed ID: 698967
[TBL] [Abstract][Full Text] [Related]
8. [Estrogen dependent plasminogen activator in breast cancer cells; experimental and clinical studies].
Yamashita J; Inada K; Matsuo S; Kawano I; Misumi A; Akagi M
Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1932-8. PubMed ID: 2514343
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
10. Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
Jordan VC
J Lab Clin Med; 1987 Mar; 109(3):267-77. PubMed ID: 3102656
[TBL] [Abstract][Full Text] [Related]
11. Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.
Wittliff JL; Mehta RG; Boyd PA; Goral JE
J Toxicol Environ Health Suppl; 1976; 1():231-56. PubMed ID: 186628
[TBL] [Abstract][Full Text] [Related]
12. Androgens and breast cancer.
Labrie F; Simard J; de Launoit Y; Poulin R; Thériault C; Dumont M; Dauvois S; Martel C; Li SM
Cancer Detect Prev; 1992; 16(1):31-8. PubMed ID: 1551135
[TBL] [Abstract][Full Text] [Related]
13. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
14. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
15. The biological significance of the interaction of estrogen agonists and antagonists with the estrogen receptor.
Murphy CS; Jordan VC
Receptor; 1990-1991 Winter; 1(1-2):65-82. PubMed ID: 2152373
[TBL] [Abstract][Full Text] [Related]
16. [Steroid receptors and endocrine control of breast tumors].
Rochefort H
Pathol Biol (Paris); 1977 Nov; 25(9):595-7. PubMed ID: 341047
[No Abstract] [Full Text] [Related]
17. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
18. Prolactin and estrogen receptors in breast cancer.
McGuire WL; Chamness GC; Horwitz KB; Zava DT
Pathobiol Annu; 1977; 7():191-211. PubMed ID: 201904
[No Abstract] [Full Text] [Related]
19. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
[TBL] [Abstract][Full Text] [Related]
20. Estradiol binding to nuclear receptors in human breast cancer tissue (MCF-7 cell line) and in dimethylbenz(a)anthracene-induced mammary carcinoma.
Geier A; Cocos M; Ginzburg R; Haimsohn M; Lunenfeld B
J Clin Endocrinol Metab; 1979 Jul; 49(1):34-9. PubMed ID: 109464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]